Reporting from the frontiers of health and medicine

Forge to buy Becker's Healthcare from Pamlico Capital in private equity shakeup

Forge to buy Becker's Healthcare from Pamlico Capital in private equity shakeup GenoMethods.org © genomethods.org
Forge to buy Becker's Healthcare from Pamlico Capital in private equity shakeup © genomethods.org
Forge, backed by Apollo, has signed a deal to buy Becker's Healthcare from Pamlico Capital. JEGI LEONIS advised on the transaction, marking a major shift in private equity healthcare holdings.

Forge, a company owned by Apollo, has signed a deal to buy Becker's Healthcare from Pamlico Capital. JEGI LEONIS advised on the transaction. This move shifts key healthcare assets between two major private equity firms.

JEGI LEONIS has a track record in big mergers and acquisitions. The firm guided Forge through the process, showing how complex and important this deal is for everyone involved.

Becker's Healthcare reaches more than 1.5 million healthcare leaders and executives through its digital products and draws over 15,000 attendees to its live events each year.

Becker's Healthcare grew under Pamlico Capital. Now, with the sale to Forge—another Apollo asset—both firms are making a clear play to strengthen their positions in the healthcare sector.

The announcement does not include the price or a closing date. But the signed agreement shows Apollo and Pamlico Capital are moving to get the most out of their investments. This deal is part of a wave of fast-paced transactions and brand mergers in healthcare, with JEGI LEONIS often leading the talks.

According to an official press release, Forge is a B2B events and media company formed after Emerald and Questex merged, following Apollo Funds' buyout in July 2026. The deal covers all of Becker’s Healthcare’s media and event assets. That includes 16 annual conferences, over a dozen digital publications, newsletters, podcasts, and executive groups. Once combined with Fierce Healthcare, the platform will run more than 35 live events each year.

Forge already owns Fierce Healthcare and Life Sciences, and the integration with Becker’s Healthcare is expected to expand Apollo’s reach across biotech, pharma, hospitals, health systems, and payers, creating an omnichannel platform for the sector.

GlobeNewswirePress Release

This is not just another portfolio swap. Private equity firms are still hungry for healthcare assets, and specialist advisors are key to getting these complex deals done. Both Forge and Becker's Healthcare are owned by big investment groups. This deal looks like a planned move to shift influence and find new ways to work together in the sector.

JEGI LEONIS keeps closing deals and rolling out new brands as deal activity hits record highs. Its role here cements its place as a top advisor for big M&A moves. Once Becker's Healthcare is under Forge, the change is set to shake up the healthcare investment market. The biggest players are not waiting around—they are moving fast to shape the industry to fit their goals.

Vivian Lin Biotech markets and transactions editor GenoMethods.org
Biotechnology Newsroom

Vivian Lin

Vivian Lin is Biotech Markets & Transactions Editor at GenoMethods, covering licensing agreements, M&A, biotech financing, company pipelines, strategic partnerships and cross-border transactions. Her reporting connects deal structure and company strategy with the scientific and clinical evidence underlying each biotechnology asset.